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Summary
Porcine circovirus 3 (PCV-3) is an emerging circovirus species that has recently been
reported in different countries around the world, suggesting a widespread circula-
tion. In this study, sera samples originating from 654 pigs of different production
phases and clinical/pathological conditions, submitted for diagnostic purposes
between 1996 and 2017, were randomly selected. Detection of PCV-3 genome in
such samples was attempted with a previously described PCR method, and the par-
tial genome sequence was obtained from selected PCV-3-positive samples from dif-
ferent years. Compiled data confirmed that PCV-3 has been circulating in the
Spanish pig population since 1996. The overall frequency of PCV-3 PCR-positive
samples in the study period was 11.47% (75 of 654). Phylogenetic analysis of
twelve PCV-3 partial sequences obtained showed a high nucleotide identity with
the already known PCV-3 sequences, with minor variations among years. No signifi-
cant correlation was found between the detection of PCV-3 and any production
phase nor clinical/pathological condition. These results confirm PCV-3 circulation at
least since 1996 in the Spanish pig population with a low/moderate frequency.
Although the information obtained was limited, PCV-3 did not appear to be linked
to any specific pathological condition or age group.
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1 | INTRODUCTION
A new circovirus species able to infect the domestic pig has been
recently described and named Porcine circovirus 3 (PCV-3). It was ini-
tially found in 2016 in tissues of swine affected by porcine dermati-
tis and nephropathy syndrome (PDNS), reproductive failure, and
cardiac and multisystemic inflammation (Palinski et al., 2017; Phan
et al., 2016) in the USA. Subsequently, other reports from Europe
(Collins, McKillen, & Allan, 2017; Faccini et al., 2017; Franzo,
Legnardi, Hjulsager et al., 2018; Stadejek, Wozniak, Miłek, & Bier-
nacka, 2017), Asia (Fan et al., 2017; Ku et al., 2017; Kwon, Yoo,
Park, & Lyoo, 2017; Shen et al., 2017; Zhai et al., 2017; Zheng et al.,
2017) and South America (Tochetto et al., 2017) described the pres-
ence of PCV-3 genome in tissue samples or sera from pigs with dif-
ferent clinical presentations as well as in healthy animals.
PCV-3 has a circular genome that contains 1,999–2,000 nucleo-
tides with two major open reading frames (ORFs) oriented in opposite
directions encoding capsid (Cap) and replicase (Rep) proteins (Palinski
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et al., 2017). A number of complete genomes of PCV-3 are available
so far, indicating a fairly high nucleotide identity ranging from 96% to
100% (Franzo, Legnardi, Hjulsager et al., 2018; Zheng et al., 2017).
Based on phylogenetic analyses, PCV-3 has a close evolutionary rela-
tionship with Fox circovirus, Canine circovirus and Bat circoviruses (Palin-
ski et al., 2017; Phan et al., 2016). PCV-3 evolution and origin are still
unknown features of this newly discovered viral agent.
PCV-3 is the third circovirus type found in swine. PCV-1 was the
first described member of the Circoviridae family around 40 years
ago (Tischer, Gelderblom, Vettermann, & Koch, 1982; Tischer, Rasch,
& Tochtermann, 1974), which has been historically considered non-
pathogenic for swine (Allan et al., 1995). By mid-late 1990s, PCV-2
was discovered in association with the so-called post-weaning multi-
systemic wasting syndrome (PMWS, nowadays known as PCV-2-sys-
temic disease, PCV2-SD) (Segales, 2012). PCV2-SD was considered a
devastating disease during more than a decade (Segales, Kekarainen,
& Cortey, 2013), although it is nowadays under control as a result of
vaccination (Segales, 2015). In spite of being discovered by late
1990s, PCV-2 was circulating in the swine population long time
before; retrospective studies have shown that PCV-2 was present in
pigs as early as 1962s and PCV2-SD already existed by mid-1980s
(Jacobsen et al., 2009). Taking into account the natural history of
previously known porcine circoviruses, it is very likely that PCV-3
has been also present within the swine population before its initial
detection in 2016. Therefore, the aim of this work was to perform a
retrospective study to detect evidence of PCV-3 infection in Spanish
serum samples of pigs collected between 1996 and 2017. Moreover,
the genetic characterization of PCV-3 during the 22-year study per-
iod based on partial sequences of the viral genome is provided.
2 | MATERIAL AND METHODS
2.1 | Retrospective swine sera
Serum samples stored at 20°C from 654 pigs submitted for diagnostic
purposes at the Veterinary Pathology Diagnostic Service of the Universi-
tat Autonoma de Barcelona (Barcelona, Spain) between 1996 and 2017
were used for this study. From 1996 to 2005, 17 to 20 sera were ran-
domly selected from the serum bank, except for the year 1996, where
only 13 serum samples were available; between 2006 and 2017, 26–74
sera were chosen. Sera corresponded to animals from different, non-
related diagnostic studies performed across years, and information about
the overall production phase and clinical/pathological status of tested
pigs is summarized in Tables 1 and 2, respectively.
2.2 | DNA extraction and polymerase chain
reactions (PCR) to detect and sequence PCV-3
DNA from 200 ll of serum samples was extracted using MagMAx™
Pathogen RNA/DNA Kit (Applied Biosystems) according to the
manufacturer’s protocol. A plasmid containing the full-length PCV-3
sequence (Franzo, Legnardi, Centelleghe et al., 2018) and double dis-
tilled water were used as positive and negative controls,
respectively. To demonstrate the presence of PCV-3 DNA in studied
samples, a conventional PCR assay was performed; according to a
previous protocol described (Franzo, Legnardi, Hjulsager et al.,
2018), three ll of extracted DNA was added to a PCR mix and
amplified using the same thermal protocol. The reaction was carried
out in a final volume of 50 ll mixture containing 10 ll of 59 PCR
Buffer, 2 ll of 10 lM dNTPs, 1 ll of 10 pmol forward primer
(located in genomic positions 233-255), 50-AAAGCCCGAAACA
CAGGTGGTGT-30 , 1 ll of 10 pmol of a reverse primer 50-TTTTCC
CGCATCCTGGAGGACCAAT- 30 (placed between nucleotide posi-
tions 718–742), 1 Units of DNA polymerase PlatinumTM SuperFiTM
(InvitrogenTM) and 32.5 ll of water. For the partial genome sequence
amplification, two specific primer pairs able to detect two overlap-
ping amplicons were used (Palinski et al., 2017): a forward 50-CAC
CGTGTGAGTGGATATAC-30 and reverse primer 50-CAAACCCACC
CTTAACAG-30 (located in the genomic positions 74–93 and 909–
927, respectively), and a forward primer 50-GTCGTCTTGGAGC
CAAGTG-30 and reverse 50-CGACCAAATCCGGGTAAGC-30 (placed
between positions 1612–1627 and 415–433, respectively). The
extracted DNA was added to a same quantity of mix as reported
above applying as well the same PCR conditions. The PCR products
were run on 1.8% TAE agarose gel and purified using NucleoSpin
Gel and PCR Clean-up (Macherey-Nagel) according to the
TABLE 1 Number of PCV-3 in serum samples from 1996 to 2017
tested by conventional PCR
Year
Number of
examined cases (n)
PCV-3 PCR-positive
cases
Percentage
(%)
1996 13 1 7.69
1997 20 2 10.00
1998 20 1 5.00
1999 19 1 5.26
2000 19 1 5.26
2001 20 2 10.00
2002 20 3 15.00
2003 20 1 5.00
2004 20 1 5.00
2005 17 0 0.00
2006 39 2 5.13
2007 39 6 15.38
2008 40 7 17.50
2009 26 0 0.00
2010 40 6 15.00
2011 39 3 7.69
2012 37 9 24.32
2013 22 3 13.64
2014 42 7 16.67
2015 41 8 19.51
2016 27 1 3.70
2017 74 10 13.51
Total 654 75 11.47
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manufacturer’s protocol. The quality and quantity of genomic DNA
was analysed with BioDrop DUO (BioDrop Ltd).
Twelve samples from different years were then Sanger
sequenced for verification at the Genomic and Bioinformatics Ser-
vice of the Universitat Autonoma de Barcelona (Barcelona, Spain),
which was performed with BigDye Terminator v3.1 Cycle Sequenc-
ing Kit, following the manufacturer’s protocol. The sequencing reac-
tions were analysed using an ABI PRISM 3130xl Genetic Analyzer
(Applied Biosystem).
2.3 | Sequence alignment and phylogenetic analysis
Sequence analysis was performed with Finch TV program 1.4.1
(http://www.geospiza.com), the consensus was obtained utilizing
ChromasPro (CromasPro Version 1.5) and sequences were aligned
with 51 PCV-3 complete genomes available at the GenBank (retrieved
on November 2017) using MAFFT (Kumar, Stecher, & Tamura, 2016).
A phylogenetic tree was conducted using the maximum-likelihood
(ML) method implemented in PhyML (Guindon et al., 2010); the
robustness of the ML tree was evaluated by bootstrap analysis with
1,000 boostrap replicates. The raw genetic distance among strains was
calculating using MEGA7 software (Kumar et al., 2016). Sequences
obtained were deposited at the GenBank (references MG807066 to
MG807089).
2.4 | Association between the presence of PCV-3
and production phase and clinical/pathological
conditions
All studied animals were classified according to their respective pro-
duction phases (lactation, from 1 to 3 weeks of age; nursery, from 4
to 9 weeks of age; fatteners, >10 weeks of age; sows and foetuses
were also included). Animals were still classified according to their
different clinical/pathological presentations (gastrointestinal, sys-
temic, neurological, reproductive, respiratory and other conditions
such as cutaneous, musculoskeletal or inconclusive clinical signs). A
number of asymptomatic animals were included as well. Table 2
summarizes the number of pigs in each production phase as well as
their clinical/pathological presentation. Specifically, as previous stud-
ies reported coinfections of PCV-3 with PCV-2 (Fu et al., 2017; Ku
et al., 2017) and Porcine reproductive and respiratory syndrome virus
(PRRSV) (Fu et al., 2017), two of the most important pathogens
affecting pigs worldwide, the concurrent presence PCV-2 and PRRSV
was also assessed. These two latter viruses were investigated for
diagnostic purposes (immunohistochemistry and/or in situ hybridiza-
tion) in just some of the studied animals, attending to the demand of
the submitting veterinarian.
2.5 | Statistical analyses
The statistical analyses were performed using XLSTAT 365 Microsoft
Excel 2016 Statistics Software. To test for significant differences
between production phases, the corresponding clinical/pathological
status and the PCV-3 PCR positivity frequencies across the 22 years
tested in this study, a Fisher’s exact test was performed. p values
<.05 were considered to be statistically significant.
3 | RESULTS
3.1 | PCV-3 detection by PCR
PCV-3 PCR positivity was found in 75 of 654 (11.46%) serum sam-
ples. The first PCV-3 PCR-positive sample dated back to 1996, and
TABLE 2 Frequencies of PCV-3-positive and -negative samples grouped according to different clinical/pathological presentations and
production phase
Clinical/pathological disorders
Production
phase
PCV-3 PCR
Results
Total
Gastrointestinal Neurological Respiratory Reproductive Systemic Others Asymptomatic
n n % n % n % n % n % n % n %
Foetuses Positive 3 0 0.00 0 0 0 0.00 3 100 0 0.00 0 0.00 0 0.00
Negative 3 0 0.00 0 0.00 0 0.00 3 100 0 0.00 0 0.00 0 0.00
Lactation Positive 10 1 10.00 2 20.00 5 50.00 0 0 1 10.00 1 10.00 0 0.00
Negative 113 29 25.66 22 19.47 6 5.31 0 0 19 16.81 37 32.74 0 0.00
Nursery Positive 36 10 27.78 2 5.56 9 25.00 0 0 10 27.78 2 5.56 3 8.33
Negative 262 49 18.70 16 6.11 67 25.57 0 0 74 28.24 30 11.45 26 9.92
Fattening Positive 21 1 4.76 2 9.52 3 14.29 0 0 10 47.62 1 4.76 4 19.05
Negative 172 13 7.56 7 4.07 35 20.35 0 0 67 38.95 10 5.81 40 23.26
Sows Positive 0 0 0.00 0 0.00 0 0.00 0 0 0 0.00 0 0.00 0 0.00
Negative 5 0 0.00 0 0 1 20.00 0 0 1 20.00 3 60.00 0 0.00
Totala Positive 70 12 17.14 6 8.57 17 24.29 3 4.29 21 30.00 4 5.71 7 10.00
Negative 555 91 16.40 45 8.11 109 19.64 3 0.54 161 29.01 80 14.41 66 11.89
Total 625 103 16.48 51 8.16 126 20.16 6 0.96 182 29.12 84 13.44 73 11.68
aNo information was available for five out 75 PCV-3 PCR-positive animals and 24 of 579 for PCV-3-negative animals.
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the viral genome was subsequently detected in sera from all tested
years except 2005 and 2009. The frequency in the positive years
ranged from 3.70% (one of 27) in 2016 to 24.32% (nine of 37) in
2012 (Table 1). No statistical differences in frequency of PCV-3 PCR
animals were observed across the years tested (p > .05).
3.2 | Sequence alignment and phylogenetic analysis
Partial sequences were obtained from 12 PCV-3 PCR-positive sam-
ples from different years and comprised part of the rep (sequence
length ranging from 848 to 949 nucleotide positions) and cap (se-
quence length ranging from 338 to 387 nucleotide positions) genes.
The phylogenetic analysis was performed on the concatenation of
the partial rep and cap sequences (covering a total of 1,001 nucleo-
tides of the whole PCV-3 genome) (Figure 1). The phylogenetic tree
and pairwise distance analysis showed more than 98% of identity
among the Spanish strains and also between the Spanish strains and
other already published PCV-3 sequences. The oldest PCV-3 partial
sequences obtained were from 1997 (GenBank references
MG807066 for Rep gene and MG807078 for Cap gene), which
shared a 98% nucleotide identity with the first PCV-3 sequence
described in the USA in 2016 (KX898030.1). Although some Spanish
clusters were identified (Figure 1), the sequences were globally scat-
tered along the phylogenetic tree.
3.3 | Association between the presence of PCV-3,
production phase and clinical/pathological conditions
The detection of PCV-3 genome split by production phase and clini-
cal/pathological conditions is summarized in Table 2. No information
about production phase and clinical/pathological condition was avail-
able for five of 75 PCV-3 PCR-positive pigs and 24 of 579 negative
ones.
Overall, 36 of 298 nursery pigs (12.08%), 21 of 193 (10.88%) fat-
teners and 10 of 123 (8.13%) lactating pigs were PCV-3 PCR posi-
tive, and no statistically significant differences were observed among
production phases (p > .05). None of the five sows tested were
PCV-3 PCR positive; in contrast, three of six (50%) foetuses were
positive.
According to the different clinical/pathological conditions, 17 of
126 (13.49%) pigs with respiratory disorders were PCV-3 PCR posi-
tive as well as 21 of 182 pigs (11.53%) with systemic problems and
12 of 103 pigs (11.65%) with gastrointestinal disorders. Likewise, the
positivity rate was identified in six of 51 pigs (11.76%) with neuro-
logical and three of six (50%) with aborted foetuses. Also, four of 84
(4.76%) pigs included in the group of other conditions and seven of
73 (9.58%) asymptomatic animals were PCV-3 PCR positive. No
statistically significant differences were observed among clinical/
pathological conditions (p > .05).
Among PCV-3 PCR-positive animals, 37 were originally tested
for PCV-2 and 45 for PRRSV. In total, nine of 37 (24.32%) and seven
of 45 (15.55%) of the PCV-3 PCR-positive cases were also positive
for PCV-2 and PRRSV, respectively.
4 | DISCUSSION
PCV-3 was first reported in 2016. Since then, many investigations
have shown the presence of its genome in pig samples from differ-
ent production phases, affected by a variety of pathological disor-
ders, and also distributed in different countries worldwide. A recent
study indicated the presence of PCV-3 genome as early as 2002 in
tissue and faecal samples in Northern Ireland (Collins et al., 2017),
suggesting that PCV-3 is not a new virus and has probably been cir-
culating for a relatively extended period in pig populations around
the world. The present retrospective investigation further confirms
such a hypothesis; PCV-3 has been circulating in the Spanish pig
population at least since 1996, the earliest year of detection of
PCV-3 worldwide to date.
Compiled data along 22 years offered a mean PCV-3 PCR-posi-
tive rate of 11.47%. These data agree with the detection frequency
found in Spanish serum samples (14 of 94; 15%) from a previous
study, whilst they are slightly lower than those obtained in Italy
(18.18%), Poland (25%), Denmark (30%), South Korea (44.20%) and
China (59.46%) (Franzo, Legnardi, Hjulsager et al., 2018; Stadejek
et al., 2017; Zheng et al., 2017). The study design of the mentioned
works was different in relation to both the studied age categories
and the PCR methodologies used, implying that a direct comparison
of positivity frequency is not feasible. Therefore, the prevalence of
the virus in the different geographical regions cannot be accurately
stated at present.
The phylogenetic analysis of obtained sequences in the present
retrospective study demonstrates a close distance between them and
with the PCV-3 genomes available at the GenBank. Even if the genetic
variability was globally low, the Spanish strains were intermingled
amongst all currently available PCV-3 sequences in the phylogenetic
tree. This result would suggest that PCV-3 has not shown a differenti-
ated independent molecular evolution in the particular areas of the
world where it has been detected so far. Moreover, the low genetic
variability found in PCV-3 would point to a recent emergence (and
consequently, a relatively short time to evolve) or, alternatively, to a
slow evolution rate as has been found for PCV-1 (Cortey & Segales,
2011). Further phylogenetic and evolutionary studies with higher num-
bers of PCV-3 sequences are needed to ascertain those hypotheses.
F IGURE 1 Phylogenetic tree based on the partial genomes (1,001 nucleotide sequences) of PCV-3 Spanish strains and PCV-3 freely
available sequences at Genbank. The phylogenetic tree was constructed using the maximum-likelihood algorithm of PhyML software with
1.000 bootstrap replicates. Spanish sequences obtained in the present study and Franzo, Legnardi, Hjulsager et al. (2018) have been coloured
in red and blue, respectively. Nodes demonstrating a branch support higher than 70% have been marked with a full circle
KLAUMANN ET AL. | 5
Some studies identified the presence of PCV-3 in several tissue
samples or sera from pigs with different clinical presentations (Palin-
ski et al., 2017; Tochetto et al., 2017; Zhai et al., 2017), as well as in
healthy animals (Franzo, Legnardi, Hjulsager et al., 2018; Franzo,
Legnardi, Centelleghe et al., 2018; Zheng et al., 2017). The data
compiled in this study suggest a homogeneous PCV-3 frequency in
the different production phases and clinical/pathological conditions,
as no statistically significant differences were found among tested
groups. Previous studies reported coinfections of PCV-3 with PCV-2
(Fu et al., 2017; Ku et al., 2017) and Porcine reproductive and respira-
tory syndrome virus (PRRSV) (Fu et al., 2017), two of the most impor-
tant pathogens affecting pigs worldwide. In the studied animals,
PCV-2 and PRRSV were investigated for diagnostic purposes attend-
ing to the demand of the submitting veterinarian. In total, 24.32%
and 15.55% of the PCV-3 PCR-positive cases were also positive for
PCV-2 and PRRSV, respectively. It is very likely that those percent-
ages of coinfections reflect the relatively widespread nature of all
these three viruses in Spain, rather than a potential synergism or
association.
Noteworthy, at least for PCV-2, the link between clinical disease
and the virus is associated with the viral load; the higher the viral
load, the higher the probability of the animal being sick (Grau-Roma
et al., 2009). Specifically, some reports have shown significant differ-
ences in PCV-2 load in serum samples, as well as in different tissues,
between healthy and sick PCV-2-SD pigs; loads above 107 PCV2
genome copies/ml or higher have been usually detected in diseased
animals (Brungborg, Moldal, & Jonassen, 2004; Olvera, Sibila, Cal-
samiglia, Segales, & Domingo, 2004). Recently, Zhai et al. (2017)
found lower qPCR Ct values in samples from animals with respira-
tory signs and diarrhoea compared to those of asymptomatic ani-
mals, suggesting that PCV-3 may be potentially associated with
these clinical conditions. A recently described qPCR for PCV-3
detection (Franzo, Legnardi, Centelleghe et al., 2018) was attempted
in the present study with a limited number of positive samples as an
exploratory approach (data not shown). Results showed Ct values
ranging from 24.23 to 39.04 (equivalent to 107and 102 PCV-3 gen-
ome copies/ml of serum), but no apparent correlation with the clini-
cal/pathological conditions was found. Definitively, more studies
trying to confirm or rule out a potential relationship of PCV-3 or cer-
tain PCV-3 loads with disease in swine are needed.
In conclusion, the current study confirms PCV-3 circulation in
the Spanish pig population with a low/moderate frequency, at least
since 1996. The high identity among PCV-3 partial genome
sequences indicates that this virus has remained relatively stable
across the years. Preliminarily, PCV-3 infection did not appear to be
linked to any specific pathological condition nor particular pig age
group or production phase.
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